TECHNOLOGY
SERVICES
PARTNERSHIPS
CMDIventusSM: Our ground breaking computational and molecular software platform: for the analysis of protein-protein and protein-peptide interactions;for the de novo design and insilico screening of peptide binders; for the modeling and design of novel peptidic molecules; to realize novel hits and leads; to create peptide therapeutics.
Deliver a best in class computational biotechnology platform for peptide discovery projects. Discover and Identify novel peptide structures as virtual screening hits; to evolve hits into therapeutic leads; understand the structural basis of protein-peptide interactions; to accelerate peptide design and optimization process.
Our business model is to build collabortive research projects with partners that leverage CMDInventusSM and our expertise in computational chemistry and peptide design. You will get quality hits, greater molecular insight accelerated screening throughput and increased diversity space coverage.
WELCOME TO CMD BIOSCIENCE
LATEST NEWS AND
INFORMATION
CMD Bioscience is a computational biotechnology company that has created a groundbreaking suite of molecular software applications known as CMDInventusSM. We Introduce and make available CMDInventusSM for the computer-aided analysis protein-protein interactions (PPIs) and for modeling and design of novel peptidic molecules which effect protein-peptide and protein-protein interactions. We developed our computational platform technology from the ground up to minimize the risk of peptide research, accelerate computer-aided drug design (CADD) and peptide drug discovery, and to create peptide therapeutics. CMD Bioscience’s expertise and computational platform technologies are unique in that we rapidly provide custom solutions to accelerate your peptide discovery projects.
Accelerating Peptide Discovery
Copyright 2012: CMD Bioscience. Computational Biotechnology. All rights reserved.
5 Science Park New Haven, CT 06511 203-298-4251 | info@cmdbioscience.com
CMD Bioscience -- A Computational Biotechnology Company
CMD Bioscience offers you CMDInventusSM, our proprietary and patented computational platform, to execute simplified and intuitive work flows, to create new chemical entities, to realize utterly novel hits and leads. You will get quality hits, greater molecular insight, accelerated screening throughput, and increased diversity space coverage. You will have shorter discovery cycles that are measured in weeks rather than months. CMDInventusSM has been fully validated across multiple research projects and target classes which are detailed on our applications page.
CMD Bioscience has established a business structure as a Collaborative Research Organization to operate in the Pharmaceutical, Biotechnology and Life Sciences space. Our corporate goals aim to deliver a best in class computational biotechnology platform for peptide drug discovery projects. Our corporate mission is to utilize our expertise, services, and technology platform to discover and identify novel peptide structures as virtual screening hits, to evolve them into therapeutic leads; to understand the structural basis of protein-peptide interactions, and to rationally design and optimize peptide therapeutics.
